Evidence map›Paper›PMID 40747113›Full record

ArticleLancet regional health. Americas2025

Descriptive epidemiology of gastric cancer in Costa Rica from 1990 to 2022 and projection of deaths to 2050: a population-based study.

Juan C Vanegas, Rolando Herrero, Cristina Barboza-Solís, Rebeca Ocampo, Guillermo Torres, Adolfo Ortiz-Barboza, Vanessa Ramírez, Clas Une, Alejandro Calderón, Carolina Porras and 2 more

Abstract read
In one paragraph

Article in Lancet regional health. Americas, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Juan C VanegasAgencia Costarricense de Investigaciones Biomédicas-Fundación INCIENSA (ACIB-FUNIN), San José, Costa Rica.
Rolando HerreroAgencia Costarricense de Investigaciones Biomédicas-Fundación INCIENSA (ACIB-FUNIN), San José, Costa Rica.
Cristina Barboza-SolísFacultad de Odontología, Universidad de Costa Rica, San Pedro, Costa Rica.
Rebeca OcampoAgencia Costarricense de Investigaciones Biomédicas-Fundación INCIENSA (ACIB-FUNIN), San José, Costa Rica.
Guillermo TorresMinisterio de Salud, Registro Nacional de Tumores, San José, Costa Rica.
Adolfo Ortiz-BarbozaEscuela De Salud Pública, Universidad de Costa Rica, San Pedro, Costa Rica.
Vanessa RamírezInstituto de Investigaciones en Salud (INISA), Sección de Nutrición Pública, Sección de Nutrición Normal y Clínica, Escuela de Nutrición, Universidad de Costa Rica, Costa Rica.
Clas UneInstitute of Health Research (INISA), University of Costa Rica, 11501-2060, San José, Costa Rica.
Alejandro CalderónCaja Costarricense de Seguro Social, Área de Investigación en Salud y Seguridad Social, San José, Costa Rica.
Carolina PorrasAgencia Costarricense de Investigaciones Biomédicas-Fundación INCIENSA (ACIB-FUNIN), San José, Costa Rica.
Loretto J CarvajalAgencia Costarricense de Investigaciones Biomédicas-Fundación INCIENSA (ACIB-FUNIN), San José, Costa Rica.
Romain FantinAgencia Costarricense de Investigaciones Biomédicas-Fundación INCIENSA (ACIB-FUNIN), San José, Costa Rica.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: In Costa Rica, gastric cancer has been the leading cause of cancer death (both sexes) since the 1980s. The objective of this study was to analyze the incidence, mortality, and geographic distribution of stomach cancer in Costa Rica for the period 1990-2022, and to make projections of deaths up to 2050. Methods: Incidence and mortality data were from the Costa Rican National Cancer Registry, the Costa Rican National Institute of Statistics and Census, and the Central American Population Research Center. Age-standardized incidence and mortality rates, annual percent changes (APC), and years of potential life lost (YPLL) were calculated. Crude mortality rates were estimated at the canton level. Mortality projections were made using Poisson models. Findings: The standardized rates have been decreasing in all ages over 40 years old, in men and in women (in incidence, APC = -4.4% [-4.6, -4.3] in men, APC = -3.6% [-3.8, -3.3] in women; in mortality APC = -3.5% [-3.7, -3.4] in men, APC = -3.0% [-3.3, -2.8] in women). YPLL rates increased with age, but the age group with the highest number of YPLL was between 50 and 69 years. High mortality rates were observed in the mountainous areas east and south of the capital region, and one canton in Guanacaste. Most models projected increases in number of deaths of 50%-200% by the year 2050. Interpretation: Despite declining mortality rates, the number of gastric cancer deaths is projected to rise, underscoring the need for targeted public health strategies-particularly programs for Funding: The study was supported by the Agencia Costarricense de Investigaciones Biomédicas-Fundación INCIENSA.

Indexed as

Costa RicaGastric cancerIncidenceMortalityProjectionsYPLL

Identifiers

PMID40747113
PMCPMC12310398

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.